Shin Dongwoo, Rew Yosup, Boger Dale L
Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):11977-9. doi: 10.1073/pnas.0401419101. Epub 2004 Jun 2.
Ramoplanin is a potent antibiotic, first disclosed in 1984, that acts by inhibiting bacterial cell-wall biosynthesis. The original ramoplanin complex was shown to consist of a mixture of three closely related compounds, ramoplanin A1-A3, of which ramoplanin A2 is the most abundant. The structure of ramoplanin A2 was unambiguously established first through a series of extensive spectroscopic studies, allowing complete stereochemical assignments and subsequently providing a minor reassignment of the side-chain double-bond stereochemistry and, most recently, through total synthesis of authentic material. Here we report the total syntheses of the aglycons of the minor components of the ramoplanin complex, A1 and A3, which unambiguously establish their structure and provide an expected structural revision for the lipid side-chain double-bond stereochemistry.
瑞莫拉宁是一种强效抗生素,于1984年首次被发现,其作用机制是抑制细菌细胞壁的生物合成。最初的瑞莫拉宁复合物被证明是由三种密切相关的化合物——瑞莫拉宁A1 - A3的混合物组成,其中瑞莫拉宁A2含量最为丰富。瑞莫拉宁A2的结构首先通过一系列广泛的光谱研究得以明确确定,从而完成了全立体化学归属,随后对侧链双键立体化学进行了微调,最近则通过全合成得到了真实的化合物。在此,我们报道了瑞莫拉宁复合物次要成分A1和A3的苷元的全合成,明确确定了它们的结构,并对脂质侧链双键立体化学进行了预期的结构修正。